| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Australia | 5 | |
| #2 | New Zealand | 4 | |
| #3 | EPO (European Patent Office) | 3 | |
| #4 | China | 2 | |
| #5 | Israel | 2 | |
| #6 | Mexico | 2 | |
| #7 | Serbia | 2 | |
| #8 | United States | 2 | |
| #9 | Costa Rica | 1 | |
| #10 | Cuba | 1 | |
| #11 | Hong Kong | 1 | |
| #12 | Republic of Korea | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Heterocyclic compounds | |
| #3 | Medical preparations | |
| #4 | Acyclic or carbocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Finch Harry | 15 |
| #2 | Bull Richard James | 11 |
| #3 | Ray Nicholas Charles | 10 |
| #4 | Bravo Jose Antonio | 5 |
| #5 | Fox Justian Craig | 4 |
| #6 | Van Den Heuvel Marco | 4 |
| #7 | Nadin Alan John | 4 |
| #8 | Fitzgerald Mary Frances | 4 |
| #9 | Avitabile Barbara Giuseppina | 3 |
| #10 | Alcaraz Lilian | 3 |
| Publication | Filing date | Title |
|---|---|---|
| US2013203716A1 | Inhaled combination therapy | |
| NZ578475A | Napadisylate salt of a muscarinic m3 antagonist | |
| EP2281813A1 | Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses | |
| AU2006212022A1 | Combination of methylxanthine compounds and steroids to treat chronic respiratory diseases | |
| NZ552899A | Methylxanthine compounds and steroids to treat chronic respiratory diseases |